Obermatt
See Similar Stocks →

TransMedics Group

NMQ:TMDX · US89377M1099
Health Care Equipment & SuppliesMedium

360

32
EV / EBIT21
Price / Owner Earnings41
Owner Earnings Yield78
Dividend Yield1
Price/Sales47
EV / Gross Profit19
Price/Book35
Return on Capital59
Cash Return on Capital94
Return on Equity99
EBIT Margin71
Gross Profitability22
Cash Conversion22
Accruals30
Owner Earnings Margin94
Sales growth75
Profit Growth70
Long-Term EPS Growth31
Reinvestment1
Price momentum17
Debt load21
Refinancing39
Debt Payback47
Liquidity67
Analyst ratings34
Opinion Changes32
Price Target Upside80
Market mood79
Value Creation14/20strong value creator
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

TransMedics Group generates returns well above its cost of capital, the foundation of durable shareholder value.

Profile

CountryUSA
IndustryHealth Care Equipment & Supplies
SizeMedium
TypePublic Company
ExchangeNASDAQGM
Founded2018
Employees572
Websitetransmedics.com
ISINUS89377M1099
Last UpdateApr 2, 2026
Indices
NASDAQ (USA)D.J. US Medical Equipment
Themes
RespiratoryStem Cell TherapyBiomedical EngineeringHealth DiagnosticsHepatology

Description

TransMedics Group, Inc., a medical technology company, transforms organ transplant therapy for end-stage organ failure patients across multiple disease states. The company developed the OCS to replace a decades-old standard of care that is significa…

Analysis

Middle-of-the-road

TransMedics Group, Inc. is a middle-of-the-road business: neither the economics nor the price stand out from the peer group.

The price is fair. You pay 18.9× its owner earnings: the cash an owner could take out each year, which is in the historically fair zone.

The trajectory is tepid and the balance sheet is stretched. The company scores 14/20 on our value-creation score: strong value creator.

Nothing is flagged here: no red or amber gates, no divergence between profits and cash. That is itself information: the numbers are straightforward. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
25
2023202420252026

All-time high

84

Jan 2023

All-time low

25

Jun 2026

Average rank

60

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
47
31
14
41
Price/Earnings
16
29
21
12
Price/Book
35
19
17
56
Dividend Yield
1
1
1
1
Value (overall)
16
15
19
47

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare TransMedics Group with its peers
Inogen
NSQ:INGN
39
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
CVRx
NSQ:CVRX
30
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
Ceribell
NSQ:CBLL
37
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
Kestra Medical Technologies
NSQ:KMTS
21
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
Quidel
NSQ:QDEL
9
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeLarge
Full Stock Analysis →
LENSAR
NAQ:LNSR
88
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →